Wu, Jr-Wei
Al-Hassany, Linda
Castaldo, Matteo
Chiang, Chia-Chun
Labastida-Ramirez, Alejandro
Messina, Roberta
Pan, Li-Ling Hope
Vuralli, Doga
Wells-Gatnik, William
Yener, Sophie Merve
Rubio-Beltrán, Eloísa
Funding for this research was provided by:
National Science and Technology Council (NSTC 114-2314-B-075-019-MY2)
National Science and Technology Council (NSTC-114-2314-B-A49-038)
Ministry of Science and Technology, Taiwan (MOST 111-2314-B-075-064-MY2)
Brain Research UK (F25-100034)
Brain Research Center, National Yang Ming Chiao Tung University
Ministry of Education
National Science and Technology Council of Taiwan (NSTC-113-2314-B-A49-026)
Migraine Trust
King's College London
Article History
Received: 15 December 2025
Accepted: 8 February 2026
First Online: 18 February 2026
Declarations
:
: Not applicable.
: Not applicable.
: All authors are Editorial Board Members of The Journal of Headache and Pain. Additionally, J-WW, reports speaker honoraria from Biogen-Idec, Pfizer, AbbVie, Eli Lilly, Organon, and HAVA Bio-Pharma. LA-H, is Member of the Methodology and Statistics Editorial Board of Neurology. C-CC is consultant for Pfizer, AbbVie, Amneal, Satsuma, and eNeura; and reports research support from the American Heart Association, Pfizer, and Lundbeck. RM, reports personal fees from AbbVie, Biomedia, Lundbeck, Organon, Pfizer, and Teva, and grants from the Italian Ministry of Health. WW-G, is Editorial Board Member of SN Comprehensive Clinical Medicine. ER-B is Associate Editor of Frontiers in Molecular Neuroscience.